HPUS Online Database →      What's This?  |  Register  |  Login

The Homœopathic Pharmacopœia of the United States

May 2014

Instructions for Submitting Public Comments On Monographs

The Board of Directors of the Homeopathic Pharmacopeia Convention of the United States (HPCUS) is pleased to announce the adoption of 6 monographs into the Homeopathic Pharmacopeia of the United States (HPUS).

The purpose of the Public Comment Period is to provide an opportunity for the homeopathic community and the general public to offer views, share thoughts and identify further questions to be considered regarding these monographs. Comments are due no later than July 31, 2014.

Providing Written Comments

Comments must be submitted in writing, either by email or U.S. Mail.

1) Comments are especially welcome by email, either in the body of the email itself, or as an MSWord attachment. You must include the name of the monograph you are commenting on in the subject line of the email. This will help ensure that the intent of your comment is most clearly conveyed to the appropriate HPCUS Committee.  Emailed comments must be sent no later than 11:59 pm PT July 31, 2014 to: clarkpbaker@verizon.net

2) Comments may also be sent by U.S. Mail, postage prepaid. Please include the name of the monograph you are commenting on at the top of page one of your letter. Mailed comments must be post marked no later than July 31 , 2014, and sent to HPCUS Editor ,4974 Quebec Street N.W., Washington DC 20016

Six New Monographs After extensive review and discussion by the Monograph Review and Pharmacopeia Revision Committees, the Board has approved the recommendations of both working groups and has added 6 sponsored substances to the list of officially monographed homeopathic drug products in the HPUS:

  • Adenosinum triphosphoricum dinitricum

  • Arteria suis

  • Barium oxalsuccinicum

  • Cerebrum suis cis -

  • Acontitum acidum

  • Levothyroxinum

Comment Review: These monographs can be accessed by subscription to the HPUS. Comments on these 6 newly approved monographed substances will be accepted for a period of 90 days ending 31 July 2014. Information on submitting public comments can be found on the home page of the HPUS (www.hpus.com). Labeling Guidelines

All timely received comments will be reviewed and considered by the Monograph Review Committee and / or the Pharmacopeia Revision Committee. Any changes proposed by either committee, as a result of the comments filed and subsequent consider ation, will be reviewed by the Board of the HPCUS.

Timeline for Changes:

Any revisions to the monographs will become effective upon final approval by the Board of the HPCUS.